company was incorporated on January 2, 2000, representative of the legal person: Cai Xiangrong. the company has equipment to improve the standardization of laboratory and workshop.
    Bo sea bio-technology co., Ltd., devoted to the biological, medical and related products in the field of technological research, development and marketing, related to molecular biology, biochemistry, medical diagnostic reagents, as well as various media for microorganisms, testing, and many other aspects.
companies focused on horizontal cooperation with forces and common development. in May 2001, and Jinan o advantage agriculture development co., Ltd., Tin FUNG and Red Cross hospitals in Shandong province to establish a cooperative relationship, a joint public Secretary, implementation of immune-type anticancer agents--industrialization production of polysaccharides from grifola frondosa. it is the company's maturation as an input for the first time, horizontal integration successful.
     Haibo biotechnology co., Ltd. products: dry medium, chromogenic medium, pharmacopoeia of the General Survey of media, media, transportation, plant tissue culture medium medium medium medium, animal vaccines, clinical inspection, one tablet
     dry culture media: there are more than 600 varieties, France imported raw materials production, stable quality, good specificity, and and constantly develop new products.
     of Mycoplasma culture medium: due to stable quality, specificity, and is widely used in skin diseases in hospitals and specialized hospitals across the country, obtains the user's consistent high praise.
     chromogenic medium: colour medium producing Staphylococcus aureus, Escherichia coli chromogenic culture media, chromogenic medium for coliforms, Escherichia coli and coliform bacteria Listeria two-in-one color, color chromogenic culture media, 0157 bacteria Vibrio culture medium, chromogenic medium, chromogenic medium for Lactobacillus Enterobacter sakazakii, etc.
     biochemical reagent: operates a number of biochemical reagents, the variety is complete, quality assurance.

company's existing technologies and projects
     Haibo company has developed business management for many years engaged in scientific research and production technology of shaft, forming a number of technically advanced and mature, production feasibility, future market, significant technical achievements and projects of economic benefits, some in the industrial production stage before the establishment of the company.
1, biological response modifiers-the polysaccharide of grifola frondosa project
    -is a kind of immune polysaccharide from grifola frondosa antitumor agents. this project was launched in 1998 in the city of Qingdao science and Technology Commission project, and declare the 2000 national torch plan. the project has pilot production completed in Qingdao economic and technological development zone. now joint Jinan o advantage agriculture development co., Ltd., Jinan Shandong province zhangqiu tianfon group and armed police hospital, Red Cross Hospital, Jinan Jinan three bio-engineering co., Ltd. jointly implement the project examination and approval of new drugs, and industrial production.
2, beer enzymes for industrial use-lactic acid decarboxylase-Alpha-acetyl
     Alpha-acetyl lactic acid decarboxylase, promote the ripening process of beer fermentation process, shorten beer fermentation cycles, increase equipment utilization.
3, metal sulfur protein (Metallothionein, MT for short) are widely present in the organisms of low-molecular-weight, Cys-rich, heavy metals that can be induced by metal-binding proteins.
     function with a number of biological activity of Metallothionein (1) on the detoxification of heavy metal ions (2) involved in the storage, transport and metabolism of trace elements (3) free radical scavenging function, SOD the main the superoxide anion radical and MT while the superoxide anion radical and hydroxyl radical (OH-), especially with · OH-rate of about 10,000 times faster than the SOD.
4 chromium-rich yeast: used in the treatment of diabetes and cancer.

company direction and strategy of
    the company was initially a clear direction for the future development and strategy. the specific scenarios in three steps.
the first, mainly for sales, production of secondary, production and sales simultaneously.
saved to development. based on the existing products and technologies, establish good market base and reputation.
Second, to projects, research and production at the same time, formed a sales network.
currently has projects of cooperation, continue to increase the intensity of cooperation, informal manner to establish a broad partnership.undefined provide good guarantees for products to enter the market.
III, in his own production-oriented, perfect sales network, created the company's brand.